SCHEMBL13411705

SCHEMBL13411705

CNC(=O)OCCn1c(=O)n(CCOC(=O)NC)c(=O)n(CCOC(=O)NC)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.47
CHRNA4 P43681 2/20 0.47
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CYP2D6 P10635 1/20 0.47
CHRM1 P11229 1/20 0.47
NFKB1 P19838 1/20 0.47
CHRM3 P20309 1/20 0.47
MAPK1 P28482 1/20 0.47
CHRNA7 P36544 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
APEX1 P27695 1/20 0.46
EPHX1 P07099 1/20 0.46
ALDH1A1 P00352 1/20 0.41
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
APOBEC3A P31941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13413720 0.89 EPHX1 (0.52) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL13413675 0.81 CREBBP (0.47) CHRNB2CHRNA4ALDH1A1KDM4EGAA
SCHEMBL13413673 0.77 MEN1 (0.43) MAPK1SMN1; SMN2ALDH1A1KDM4EGAA
SCHEMBL10036477 0.76 MGLL (0.50) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL13413672 0.76 CHRNB2 (0.45) CHRNB2CHRNA4SMN1; SMN2ALDH1A1CREBBP
SCHEMBL16541245 0.75 CHRNB2 (0.65) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL8724484 0.74 GAA (0.45) ALDH1A1KDM4EGAAGLAPOLB
SCHEMBL12810406 0.74 ACHE (0.35) CHRNB2CHRNA4ALDH1A1KDM4EGAA
SCHEMBL13413674 0.74 ACHE (0.42) SMN1; SMN2LMNA
SCHEMBL19652445 0.73 GAA (0.66) ALDH1A1KDM4EGAAPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100071574-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20100071574-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20100075500-A1 Metal polishing slurry and chemical mechanical polishing method FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20100075500-A1 Metal polishing slurry and chemical mechanical polishing method FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075500-A1 Metal polishing slurry and chemical mechanical polishing method NOX1, NOXO1, PIEZO1 CHRNB2 645/4885CHRNA4 1133/4885CHRM2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.